Previous 10 | Next 10 |
Company Expands Product Portfolio with Next Generation Product Candidate Anticipated in 2022 Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that its high oleic low linolenic (HOLL) soybean has been deemed a non-regulated article under the “Am ...
Calyxt, Inc. (CLXT) Q1 2020 Earnings Conference Call May 7, 2020 8:30 AM ET Company Participants Chris Tyson – Managing Director-MZ North America Jim Blome – Chief Executive Officer Bill Koschak – Chief Financial Officer Keith Blanks – Senior Vice Pr...
The following slide deck was published by Calyxt, Inc. in conjunction with their 2020 Q1 earnings Read more ...
First Quarter 2020 Revenue of $2.4 Million Provides Update on COVID-19 Impact Announces Extended Cash Runway and Revises 2020 Cash Usage Guidance to between $30 Million to $34 Million Management to Host Conference Call Today at 8:30 a.m. EST Calyxt, Inc. (NASDAQ: CLXT...
Building on Our B2B Platform, Calyxt is Deploying a New Retail Option for Domestically Grown Cooking Oil Through New E-Commerce Website Allergen and Gluten-Free, With Zero Grams Trans-Fat Per Serving Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched a...
Previously Scheduled Virtual Analyst Day Postponed to Later Date Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, May 7, 2020 at 8:30 a.m. Eastern time to discuss its results for the first quarter ended March 31, 2020. A press r...
Unique Technology Has Potential to Reduce Gene Edited Plant Production Timelines & Increase Speed to Market Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. Th...
Improved Navigation and Functionality Supports Increased Virtual Connectivity with Customers, Collaborators and Growers Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched its new website to showcase how Calyxt is harnessing the ‘Power and Possibilitie...
Gainers: Digirad DRAD +122% . More news on: Tocagen Inc., Menlo Therapeutics Inc., ObsEva SA, Stocks on the move, , Read more ...
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Buy rating and $69 (55% upside) price target at Citigroup. More news on: ACADIA Pharmaceuticals Inc., Alector, Inc., GW Pharmaceuticals plc, Healthcare stocks news, , Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...